Sponsored by Bayer logo

Fast Facts

DMEPOS competitive bidding process will begin April 2007.
CMS has announced the 10 MSAs where competitive bidding will be introduced.
CMS has announced the product categories included in the first competitive bidding project.
The Final Rule governing competitive bidding ensures that at least 30 percent of bid winners are small businesses.
Suppliers must obtain accreditation to participate in competitive bidding. The ONLY exception to the rule is a pharmacy that maintains a Part B supplier billing number to submit Part B drug claims and administer vaccinations.
Ten agencies have been approved to accredit suppliers of DMEPOS.

Subscribe to Blog XML Feeds:
RSS | Atom

NCPA-PRS DMEPOS Accreditation Prep Program

If your pharmacy bills Medicare Part B for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), such as diabetic supplies, mobility aids, wound care, urological, and/or respiratory supplies, then your pharmacy will need to be accredited to maintain your Medicare Part B provider number. The DMEPOS Accreditation Prep Program can help you prepare!

Comprehensive and easy-to-use, this CD-based computer software program contains the standards, policies, procedures, and forms necessary for accreditation. Using Microsoft Word and Excel, you can customize the documents to fit your pharmacy operation and print a DMEPOS Accreditation Policy and Procedure Manual for your pharmacy. A compliance guide and "how-to" section on competitive bidding also are included. This dynamic software program will save you hours in prep time!

The National Community Pharmacists Association (NCPA) has partnered with industry expert PRS to develop this accreditation program. PRS has 25 years of experience in providing pharmacy programs, including its nationally acclaimed HIPAA compliance program.

Order you copy of the DMEPOS Accreditation Prep Program TODAY!

Bayer HealthCare, Diabetes Care, has underwritten the costs of this communication. The information expressed in this communication are the views of NCPA. Bayer is not responsible for the accuracy of the information expressed in this communication. Any questions related to DME Accreditation and/or Competitive Bidding for DMEPOS should be directed to the Centers for Medicare and Medicaid Services or NCPA.